B
Bpifrance Portfolio holdings
AUM
$2.09B
This Quarter Return
-4.04%
1 Year Return
-46.97%
3 Year Return
-14.84%
5 Year Return
-4.77%
10 Year Return
–
AUM
$4.36B
AUM Growth
+$4.36B
(-3.2%)
Cap. Flow
+$22.5M
Cap. Flow
% of AUM
0.52%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
–
Reduced
–
Closed
1
Top Buys
| 1 |
Veracyte
VCYT
|
$23.3M |
Top Sells
| 1 |
CRISPR Therapeutics
CRSP
|
$777K |
Sector Composition
| 1 | Consumer Discretionary | 84.86% |
| 2 | Materials | 7.06% |
| 3 | Energy | 4.3% |
| 4 | Communication Services | 2.29% |
| 5 | Healthcare | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Stellantis
STLA
$27.8B
| $3.7B | 84.86% | 192,703,907 | – | – |
|
2
Constellium
CSTM
$2.02B
| $308M | 7.06% | 16,393,903 | – | – |
|
3
TechnipFMC
FTI
$15.1B
| $187M | 4.3% | 24,688,691 | – | – |
|
4
Criteo
CRTO
$1.3B
| $99.6M | 2.29% | 2,718,752 | – | – |
|
|
5
Veracyte
VCYT
$2.39B
| $23.3M | 0.54% | +501,941 | New | +$23.3M |
|
|
VECT
6
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $21.7M | 0.5% | 2,806,217 | – | – |
|
|
SQNS
7
Sequans Communications
SQNS
$129M
| $14.5M | 0.33% | 3,300,018 | – | – |
|
|
CLLS
8
Cellectis
CLLS
$258M
| $5.37M | 0.12% | 425,726 | – | – |
|
|
9
CRISPR Therapeutics
CRSP
$4.71B
| – | – | -4,800 | Closed | -$777K |
|